Anti-Hepatitis B Virus Surface Antigen antibody [3E7], prediluted
Be the first to review this product! Submit a review
|
(4 Publications)
Mouse Monoclonal HBSAG antibody. Suitable for IHC-P and reacts with Hepatitis B virus samples. Cited in 4 publications.
View Alternative Names
Large envelope protein, L glycoprotein, L-HBsAg, Large S protein, Large surface protein, Major surface antigen, LHB, S
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Hepatitis B Virus Surface Antigen antibody [3E7], prediluted (AB859)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Hepatitis B infected liver tissue labeling Hepatitis B Virus Surface Antigen with ab859.
Reactivity data
Properties and storage information
Form
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The Hepatitis B Virus Surface Antigen interacts with the host's immune system and assists in viral replication. HBsAg is not part of a larger protein complex. Rather it circulates as free particles known as 3e-7 and 3e-7 Hepatitis B antigens which are abundant in the blood serum during active infection. These particles act as decoys distracting the host's immune defense and facilitating the persistence of the infection. The production and clearance of HBsAg serve as important indicators of HBV infection status and disease progression.
Pathways
Hepatitis B Virus Surface Antigen plays an integral role in the HBV life cycle particularly within the viral entry and replication pathways. It shares a functional relationship with the HB5 protein which is important for viral particle assembly and release. The interactions between HBsAg and host proteins influence viral propagation and subsequently the overall pathway of HBV infection within hepatocytes. Understanding these interactions can aid in the development of therapeutic interventions to disrupt the viral lifecycle.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (4)
Recent publications for all applications. Explore the full list and refine your search
Journal of virology 98:e0150223 PubMed38315015
2024
Applications
Unspecified application
Species
Unspecified reactive species
Vaccines 11: PubMed38140229
2023
Applications
Unspecified application
Species
Unspecified reactive species
European journal of gastroenterology & hepatology 33:76-82 PubMed32049678
2020
Applications
Unspecified application
Species
Unspecified reactive species
Stem cell research 9:35-48 PubMed22640926
2012
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com